SEC Filings

Filing date	Form	Description	View
05/05/16	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-16-023937.pdf 0001179110-16-023937.rtf 0001179110-16-023937.xls
05/05/16	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-16-023941.pdf 0001179110-16-023941.rtf 0001179110-16-023941.xls
05/05/16	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-16-023939.pdf 0001179110-16-023939.rtf 0001179110-16-023939.xls
05/05/16	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-16-023940.pdf 0001179110-16-023940.rtf 0001179110-16-023940.xls
05/05/16	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-16-023938.pdf 0001179110-16-023938.rtf 0001179110-16-023938.xls
05/05/16	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-16-023945.pdf 0001179110-16-023945.rtf 0001179110-16-023945.xls
05/04/16	8-K	Report of unscheduled material events or corporate event	View HTML 0001102624-16-002678.pdf 0001102624-16-002678.rtf 0001102624-16-002678.xls
05/02/16	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-16-116438.pdf 0001104659-16-116438.rtf 0001104659-16-116438.xls
04/29/16	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-16-012708.pdf 0001047469-16-012708.rtf 0001047469-16-012708.xls
04/29/16	FWP	FWP	View HTML 0001104659-16-115511.pdf 0001104659-16-115511.rtf 0001104659-16-115511.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.